Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学CLL BTK Resistance Research

Constantine Tam

MBBS, MD

🏢Peter MacCallum Cancer Centre🌐Australia

Professor of Haematology

52
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Constantine Tam is a key investigator in next-generation BTK inhibitor development who led pivotal trials of zanubrutinib in CLL. His research on the improved selectivity and cardiovascular safety profile of zanubrutinib versus ibrutinib has influenced treatment selection. He leads CLL clinical research across the Asia-Pacific region.

Share:

🧪Research Fields 研究领域

Zanubrutinib
Next-gen BTK inhibitors
CLL Asia-Pacific
BTK inhibitor selectivity
Atrial fibrillation BTKi

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Constantine Tam 的研究动态

Follow Constantine Tam's research updates

留下邮箱,当我们发布与 Constantine Tam(Peter MacCallum Cancer Centre)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment